{
    "SPADE_UN_20427": {
        "Sequence Information": {
            "Peptide Name": "K3-DKDKC12",
            "Sequence": "XDKDKXKKK",
            "Sequence Length": 9,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Development of New Antimicrobial Agents from Cationic PG-Surfactants Containing Oligo-Lys Peptides.",
                    "Pubmed ID": "30354128",
                    "Reference": "Bioconjug Chem. 2018;:",
                    "Author": "Kimura R, Shibata M, Koeda S, Miyagawa A, Yamamura H, Mizuno T",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/30354128"
                }
            ],
            "SPADE ID": "SPADE_UN_20427",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_12729",
                    "Similarity": 1.0,
                    "Sequence": "KDKDK"
                },
                {
                    "SPADE_ID": "SPADE_N_12730",
                    "Similarity": 1.0,
                    "Sequence": "KKDKDK"
                },
                {
                    "SPADE_ID": "SPADE_N_12731",
                    "Similarity": 1.0,
                    "Sequence": "KKKDKDK"
                }
            ],
            "Hemolytic Activity": "Rabbit erythrocytes:50% Hemolysis=>952 µg/ml",
            "Target Organism": "Escherichia coli K-12 W3110(MIC=8µg/ml),Salmonella enterica subsp. enterica serovar Typhimurium LT2(MIC=16µg/ml),Staphylococcus aureus FDA 209P(MIC=8µg/ml),Bacillus subtilis 168(MIC=4µg/ml)"
        }
    }
}